Literature DB >> 31166011

Crosstalk between the lncRNA UCA1 and microRNAs in cancer.

Wei Xuan1, Hongyu Yu2, Xiaoling Zhang3, Dandan Song4.   

Abstract

Long non-coding RNAs (lncRNAs) are a major subset of highly conserved non-coding RNAs (ncRNAs) that consist of at least 200 nucleotides and have limited protein-coding potential. Cumulative data have shown that lncRNAs are deregulated in many types of cancer and may control pathophysiological processes of cancer at various levels, including transcription, post-transcription and translation. Recently, lncRNAs have been demonstrated to interact with microRNAs (miRNAs), another major subset of ncRNAs, which regulate physiological and pathological processes by inhibiting target mRNA translation or promoting mRNA degradation. The lncRNA urothelial carcinoma-associated 1 (UCA1) has recently gained much attention as it is overexpressed in many types of cancer and is involved in carcinogenesis. Here, we review the crosstalk between UCA1 and miRNAs during the pathogenesis of cancer, with a focus on cancer-cell proliferation, invasion, drug resistance, and metabolism.
© 2019 Federation of European Biochemical Societies.

Entities:  

Keywords:  UCA1; cancer; drug resistance; invasion; metabolism; micro RNA; proliferation

Mesh:

Substances:

Year:  2019        PMID: 31166011     DOI: 10.1002/1873-3468.13470

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  LINC00092 Modulates Oxidative Stress and Glycolysis of Breast Cancer Cells via Pyruvate Carboxylase-Mediated AKT/mTOR Pathway.

Authors:  Wei Chen; Yushan Liu; Shaohong Kang; Xinying Lv; Wenfen Fu; Jie Zhang; Chuangui Song
Journal:  Oxid Med Cell Longev       Date:  2022-06-28       Impact factor: 7.310

2.  Detection of lncRNA by LNA-Based In Situ Hybridization in Paraffin-Embedded Cancer Cell Spheroids.

Authors:  Boye Schnack Nielsen; Jesper Larsen; Jakob Høffding; Son Ly Nhat; Natasha Helleberg Madsen; Trine Møller; Bjørn Holst; Kim Holmstrøm
Journal:  Methods Mol Biol       Date:  2021

3.  LncRNA DANCR Promotes Sorafenib Resistance via Activation of IL-6/STAT3 Signaling in Hepatocellular Carcinoma Cells.

Authors:  Yuan Liu; Lamei Chen; Huabing Yuan; Shenghong Guo; Gang Wu
Journal:  Onco Targets Ther       Date:  2020-02-05       Impact factor: 4.147

4.  Assessment of biochemical recurrence of prostate cancer (Review).

Authors:  Xiaozeng Lin; Anil Kapoor; Yan Gu; Mathilda Jing Chow; Hui Xu; Pierre Major; Damu Tang
Journal:  Int J Oncol       Date:  2019-10-04       Impact factor: 5.650

5.  Long non-coding RNA UCA1 promotes malignant phenotypes of renal cancer cells by modulating the miR-182-5p/DLL4 axis as a ceRNA.

Authors:  Wei Wang; Wentao Hu; Ya Wang; Yong An; Lei Song; Panfeng Shang; Zhongjin Yue
Journal:  Mol Cancer       Date:  2020-01-29       Impact factor: 27.401

Review 6.  LncRNA as a multifunctional regulator in cancer multi-drug resistance.

Authors:  Jiaying He; Shaomi Zhu; Xin Liang; Qinxiu Zhang; Xiaohong Luo; Chi Liu; Linjiang Song
Journal:  Mol Biol Rep       Date:  2021-07-31       Impact factor: 2.316

7.  lncRNA IGHCγ1 Acts as a ceRNA to Regulate Macrophage Inflammation via the miR-6891-3p/TLR4 Axis in Osteoarthritis.

Authors:  Pengjun Zhang; Jianmei Sun; Caihong Liang; Bingjie Gu; Yang Xu; Hongying Lu; Bo Cao; Hao Xu
Journal:  Mediators Inflamm       Date:  2020-01-17       Impact factor: 4.711

8.  HMGB1 regulates SNAI1 during NSCLC metastasis, both directly, through transcriptional activation, and indirectly, in a RSF1-IT2-dependent manner.

Authors:  Xiao-Jin Wu; Yuan-Yuan Chen; Wen-Wen Guo; Tao Li; Hai-Bei Dong; Wei Wang; Min Xie; Gao-Lei Ma; Dong-Sheng Pei
Journal:  Mol Oncol       Date:  2020-05-06       Impact factor: 6.603

9.  Long noncoding RNA SNHG14 promotes the aggressiveness of retinoblastoma by sponging microRNA‑124 and thereby upregulating STAT3.

Authors:  Xiaowen Sun; Hui Shen; Shubin Liu; Jing Gao; Shuyan Zhang
Journal:  Int J Mol Med       Date:  2020-03-20       Impact factor: 4.101

10.  LncRNA UCA1 promotes development of gastric cancer via the miR-145/MYO6 axis.

Authors:  An Yang; Xin Liu; Ping Liu; Yunzhang Feng; Hongbo Liu; Shen Gao; Limin Huo; Xinyan Han; Jurong Wang; Wei Kong
Journal:  Cell Mol Biol Lett       Date:  2021-07-08       Impact factor: 5.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.